DOJ, US Atty Subpoena GSK Over Avandia, HIV Drugs
GSK made the disclosures alongside an announcement detailing its third-quarter earnings. The company said the subpoenas sought information regarding the development and marketing of Avandia and the marketing and sales of the HIV products, which were not identified.
The company also said it believed the information requests...
To view the full article, register now.